Related references
Note: Only part of the references are listed.Risk of Developing Pneumonia Is Enhanced by the Combined Traits of Fluoroquinolone Resistance and Type III Secretion Virulence in Respiratory Isolates of Pseudomonas aeruginosa
Eva Sullivan et al.
CRITICAL CARE MEDICINE (2014)
Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries
Mariana Castanheira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes
Qin Lu et al.
CRITICAL CARE (2014)
Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones
Xavier Mulet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Bacterial and Clinical Characteristics of Health Care- and Community-Acquired Bloodstream Infections Due to Pseudomonas aeruginosa
Angela Hattemer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
Carmen Pena et al.
CLINICAL INFECTIOUS DISEASES (2013)
Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?
Alejandro Beceiro et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality
C. Pena et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Dissemination of metallo-β-lactamase-producing Pseudomonas aeruginosa of sequence type 235 in Asian countries
Moon Jung Kim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study
Mikhail V. Edelstein et al.
LANCET INFECTIOUS DISEASES (2013)
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Clinical outcomes of type III Pseudomonas aeruginosa bacteremia
Ali A. El-Solh et al.
CRITICAL CARE MEDICINE (2012)
Clinical populations of Pseudomonas aeruginosa isolated from acute infections show a wide virulence range partially correlated with population structure and virulence gene expression
Hussnain A. Janjua et al.
MICROBIOLOGY-SGM (2012)
Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa
Melissa Agnello et al.
PLOS ONE (2012)
Most Multidrug-Resistant Pseudomonas aeruginosa Isolates from Hospitals in Eastern France Belong to a Few Clonal Types
Pascal Cholley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235
Makaoui Maatallah et al.
PLOS ONE (2011)
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance
Neil Woodford et al.
FEMS MICROBIOLOGY REVIEWS (2011)
Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 and GES-5 in Spain
Esther Viedma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies
Jeffrey L. Veesenmeyer et al.
CRITICAL CARE MEDICINE (2009)
Role of Pseudomonas aeruginosa type III effectors in disease
Joanne Engel et al.
CURRENT OPINION IN MICROBIOLOGY (2009)
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Alan R. Hauser
NATURE REVIEWS MICROBIOLOGY (2009)
Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa
A. Wong-Beringer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients with Pseudomonas aeruginosa Bacteremia
K. W. Garey et al.
JOURNAL OF CHEMOTHERAPY (2008)
A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates
David W. Wareham et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2007)
The biological cost of mutational antibiotic resistance: any practical conclusions?
Dan I. Andersson
CURRENT OPINION IN MICROBIOLOGY (2006)
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome
CI Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
mlstdbNet - distributed multi-locus sequence typing (MLST) databases
KA Jolley et al.
BMC BIOINFORMATICS (2004)
Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa
B Curran et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia
E Chamot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa
AR Hauser et al.
CRITICAL CARE MEDICINE (2002)
Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
H Feltman et al.
MICROBIOLOGY-SGM (2001)
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections
A Roy-Burman et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Share Paper
